Tags: forest labs | earnings | profit | drugs

Forest Labs Posts Profit, Raises Full-year Forecast

Tuesday, 21 Jan 2014 07:24 AM

Forest Laboratories Inc posted a profit in the first full quarter under new Chief Executive Brent Saunders, helped by higher sales of its Alzheimer's disease and hypertension drugs.

Forest said it expects adjusted earnings for its fiscal year ending March 31 in the range of $1.25 to $1.35 per share. The company in October forecast earnings of 95 cents to $1.15 per share.

The company reported a net income of about $18 million, or 7 cents per share, in the third quarter ended Dec. 31, from a loss of $153.6 million, or 58 cents per share, a year earlier.

Total revenue rose about 23 percent to $878.4 million.

 

 

 

 

 

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Companies
Forest Laboratories Inc posted a profit in the first full quarter under new Chief Executive Brent Saunders, helped by higher sales of its Alzheimer's disease and hypertension drugs.
forest labs,earnings,profit,drugs
108
2014-24-21
Tuesday, 21 Jan 2014 07:24 AM
Newsmax Inc.
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved